Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins

The aim of the review is to summarize contemporary views on mechanisms of the systemic inflammation in patients with coronary heart disease after coronary artery bypass grafting (CABG). The information about the prognostic value of activation of the inflammatory markers, such as C-reactive protein (...

Full description

Saved in:
Bibliographic Details
Main Authors: O.J. Zharinov, O.A. Yepanchintseva, I.V. Shklianka, A.I. Kurchenko, B.M. Todurov
Format: Article
Language:English
Published: TOV Chetverta Khvylia 2016-03-01
Series:Кардіохірургія та інтервенційна кардіологія
Subjects:
Online Access:http://csic.com.ua/images/pdf/2016/1-2016/markery-vospaleniya-do-i-posle-aortokoronarnogo-shuntirovaniya.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570203919089664
author O.J. Zharinov
O.A. Yepanchintseva
I.V. Shklianka
A.I. Kurchenko
B.M. Todurov
author_facet O.J. Zharinov
O.A. Yepanchintseva
I.V. Shklianka
A.I. Kurchenko
B.M. Todurov
author_sort O.J. Zharinov
collection DOAJ
description The aim of the review is to summarize contemporary views on mechanisms of the systemic inflammation in patients with coronary heart disease after coronary artery bypass grafting (CABG). The information about the prognostic value of activation of the inflammatory markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor (TNF) is provided. It is shown that elevated levels of high-sensitive CRP before CABG and high levels of TNF and IL-6 during postoperation period may be associated with hemodynamic disorders and increasing the frequency of early complications and more likely occurrence of restenosis at long-term follow-up. Therefore, the study of inflammatory markers may provide valuable information about short- and long-term prognosis after CABG. Statin medications reveal highly anti-inflammatory activity and reduce the risk of coronary events and atrial fibrillation after CABG surgery. The use of statins before and after revascularization surgery reduces the risk of acute coronary syndrome and the level of perioperative mortality by 30–42 %, and is effective for the prevention of complications within one year after CABG surgery.
format Article
id doaj-art-4cf9e8b2250841d684f77cc47e10b479
institution Kabale University
issn 2305-3127
language English
publishDate 2016-03-01
publisher TOV Chetverta Khvylia
record_format Article
series Кардіохірургія та інтервенційна кардіологія
spelling doaj-art-4cf9e8b2250841d684f77cc47e10b4792025-02-02T16:03:38ZengTOV Chetverta KhvyliaКардіохірургія та інтервенційна кардіологія2305-31272016-03-011 (12)512Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statinsO.J. Zharinov0O.A. Yepanchintseva1I.V. Shklianka2A.I. Kurchenko3B.M. Todurov4Shupyk National Medical Academy of Postgraduate Education of Healthcare Ministry of Ukraine, Kyiv, UkraineHeart Institute of Healthcare Ministry of Ukraine, Kyiv, UkraineHeart Institute of Healthcare Ministry of Ukraine, Kyiv, UkraineO.O. Bogomolets National Medical University, Kyiv, UkraineHeart Institute of Healthcare Ministry of Ukraine, Kyiv, UkraineThe aim of the review is to summarize contemporary views on mechanisms of the systemic inflammation in patients with coronary heart disease after coronary artery bypass grafting (CABG). The information about the prognostic value of activation of the inflammatory markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor (TNF) is provided. It is shown that elevated levels of high-sensitive CRP before CABG and high levels of TNF and IL-6 during postoperation period may be associated with hemodynamic disorders and increasing the frequency of early complications and more likely occurrence of restenosis at long-term follow-up. Therefore, the study of inflammatory markers may provide valuable information about short- and long-term prognosis after CABG. Statin medications reveal highly anti-inflammatory activity and reduce the risk of coronary events and atrial fibrillation after CABG surgery. The use of statins before and after revascularization surgery reduces the risk of acute coronary syndrome and the level of perioperative mortality by 30–42 %, and is effective for the prevention of complications within one year after CABG surgery.http://csic.com.ua/images/pdf/2016/1-2016/markery-vospaleniya-do-i-posle-aortokoronarnogo-shuntirovaniya.pdfcoronary artery bypass graftingsystemic inflammation
spellingShingle O.J. Zharinov
O.A. Yepanchintseva
I.V. Shklianka
A.I. Kurchenko
B.M. Todurov
Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
Кардіохірургія та інтервенційна кардіологія
coronary artery bypass grafting
systemic inflammation
title Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
title_full Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
title_fullStr Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
title_full_unstemmed Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
title_short Markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
title_sort markers of inflammation before and after coronary artery bypass grafting and the effectiveness of statins
topic coronary artery bypass grafting
systemic inflammation
url http://csic.com.ua/images/pdf/2016/1-2016/markery-vospaleniya-do-i-posle-aortokoronarnogo-shuntirovaniya.pdf
work_keys_str_mv AT ojzharinov markersofinflammationbeforeandaftercoronaryarterybypassgraftingandtheeffectivenessofstatins
AT oayepanchintseva markersofinflammationbeforeandaftercoronaryarterybypassgraftingandtheeffectivenessofstatins
AT ivshklianka markersofinflammationbeforeandaftercoronaryarterybypassgraftingandtheeffectivenessofstatins
AT aikurchenko markersofinflammationbeforeandaftercoronaryarterybypassgraftingandtheeffectivenessofstatins
AT bmtodurov markersofinflammationbeforeandaftercoronaryarterybypassgraftingandtheeffectivenessofstatins